Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crowning
San Diego, California, United Statescrownbio.com ↗
- Ownership
- Private
- Employees
- ~1300
- Development stage
- Other
01
Overview
Crown Bioscience has contributed to over six FDA-approved oncology drugs in 2021 and provides industry-leading preclinical, translational, and drug discovery testing platforms, including the world's largest commercially available patient-derived xenograft (PDX) collection and OrganoidXplore screening service for oncology indications.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- AntibodyAntibody-drug conjugateSmall moleculeMonoclonal antibodyPatient-derived xenograftOrganoid
- Industry
- Contract Research Organization
02
Partnerships
Hubrecht Organoid Technology (HUB)
Beyond the preview
Go deeper on Crowning.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crowning.